• Fluorescein Tyramide: Amplifying Signal Detection in IHC & I

  2026-06-27

  Fluorescein Tyramide empowers researchers to detect low-abundance targets with unmatched sensitivity using tyramide signal amplification. Applied in neural circuit mapping and behavioral neuroscience, this fluorescent labeling dye optimizes IHC, ISH, and flow cytometry workflows—enabling precise, reproducible results even in high-complexity tissue contexts.

• Tigecycline and Glycylcycline Antibiotics: Assay Innovation

  2026-06-26

  Explore Tigecycline as a pioneering glycylcycline antibiotic for multidrug-resistant bacteria. This in-depth article uniquely connects molecular resistance dynamics to advanced antimicrobial assay design, offering actionable insights for translational research.

• Epigenetic Mechanisms of Prenatal Dexamethasone on Bone Form

  2026-06-26

  This study reveals that prenatal dexamethasone exposure in mice reduces osteoprogenitor proliferation and postnatal bone mass through persistent histone modifications at the Mkp-1 gene locus. These findings provide new insight into how early glucocorticoid exposure programs long-term skeletal health via epigenetic pathways.

• Advanced Applications of SAG in Mitochondrial and Myelin Rep

  2026-06-25

  Explore how Smoothened Agonist (SAG) drives breakthroughs in myelin regeneration and mitochondrial modulation via direct Hedgehog pathway activation. This article provides a unique, in-depth assay and translational perspective on SAG, with practical guidance for research design.

• S Tag Peptide: Technical Guidance for Fusion Tag Application

  2026-06-25

  S Tag Peptide (SKU A6007) enables reliable detection and purification of recombinant proteins, especially in workflows requiring improved solubility and robust anti-S-Tag antibody compatibility. It is best suited for protocols where ethanol solubility is not required and where validated anti-S-Tag detection systems are in place. Avoid use in workflows lacking compatible detection antibodies or requiring long-term peptide solution storage.

• Degarelix Acetate: Advanced Protocols for GnRH Antagonist Re

  2026-06-24

  Degarelix acetate, a potent GnRH receptor antagonist, delivers rapid and reliable hormone suppression for reproductive and prostate cancer research. Explore optimized workflows, troubleshooting strategies, and translational insights that set APExBIO’s Degarelix acetate apart in both in vitro and in vivo experimental settings.

• Fludarabine as a DNA Synthesis Inhibitor: Advanced Oncology

  2026-06-23

  Fludarabine is redefining leukemia and multiple myeloma research by offering precise, mechanism-driven control over DNA synthesis inhibition, apoptosis induction, and cell cycle arrest. This article delivers actionable protocols, troubleshooting guidance, and strategic insights for leveraging APExBIO's Fludarabine in translational oncology assays.

• Macrocyclic Hedgehog Pathway Inhibitors: Mechanisms and Assa

  2026-06-23

  This article reviews the development and mechanistic characterization of potent macrocyclic inhibitors targeting the Hedgehog signaling pathway, as reported in Dockendorff et al. The study refines inhibitor design using a modular synthesis approach and details their distinct antagonism at the Smoothened receptor, with implications for cancer and developmental biology assays.

• Strategic Autophagy Inhibition: MRT68921 and the ULK1 Axis

  2026-06-22

  Translational researchers face unprecedented complexity in dissecting autophagy’s dualistic role in energy stress. Recent mechanistic insights reveal that AMPK restrains, rather than promotes, ULK1-driven autophagy initiation under metabolic crisis. This article bridges these new biological paradigms with actionable guidance and protocol strategy, leveraging the precision of MRT68921—APExBIO’s dual ULK1/2 inhibitor—to empower robust, reproducible autophagy inhibition. We critically contrast MRT68921’s selectivity and workflow compatibility against legacy tools, contextualize its use for translational models, and chart a vision for next-generation autophagy-targeted interventions.

• AG-120 (Ivosidenib): Evidence and Protocols for Mutant IDH1

  2026-06-22

  AG-120 (Ivosidenib) is an orally bioavailable, selective inhibitor of mutant IDH1, clinically validated for reducing the oncometabolite 2-hydroxyglutarate in AML. Its efficacy is demonstrated by restoring myeloid differentiation and inhibiting aberrant proliferation in IDH1-mutant cells. Protocol integration requires careful attention to solubility, storage, and resistance mechanisms.

• EdU Imaging Kits (Cy3): Unveiling S100P-Mediated Proliferati

  2026-06-21

  Explore how EdU Imaging Kits (Cy3) enable nuanced, high-fidelity detection of DNA synthesis in the S-phase, uniquely empowering research on complex cell cycle regulation and tumor biology. This article offers a new dimension by connecting EdU-based assays to the S100P/MYBL2/AURKB axis in hepatocellular carcinoma.

• HyperScript™ Reverse Transcriptase: High-Fidelity cDNA Synth

  2026-06-20

  HyperScript™ Reverse Transcriptase from APExBIO offers unmatched efficiency for RNA templates with complex secondary structures or low abundance, setting new standards in cDNA synthesis for qPCR and advanced molecular workflows. Its enhanced thermal stability and reduced RNase H activity streamline the reverse transcription process, ensuring robust, reproducible results even in challenging experimental contexts.

• Aryl Hydrocarbon Receptor Drives MEHP Ovarian Toxicity in Mi

  2026-06-19

  This study demonstrates that the aryl hydrocarbon receptor (AhR) mediates the toxic effects of mono(2-ethylhexyl) phthalate (MEHP) on mouse ovarian antral follicles. By using the AhR antagonist CH 223191, the authors provide mechanistic evidence that AhR activation is a key driver of impaired follicle growth and disrupted estrogen signaling, supporting targeted investigation of environmental endocrine disruptors in reproductive toxicology.

• LY364947: TGF-β Type I Receptor Kinase Inhibitor for EMT and

  2026-06-19

  LY364947 offers precise control of TGF-β signaling for EMT inhibition and fibrosis models, standing out for its robust suppression of Smad2 phosphorylation and versatile application in both in vitro and in vivo research. Its solubility, potency, and proven performance make it a gold-standard tool for dissecting pathway crosstalk in cancer and retinal degeneration studies.

• Berberrubine Chloride: Protocols for Cancer & Metabolic Rese

  2026-06-18

  Berberrubine chloride enables multi-pathway targeting in cancer, inflammation, and metabolic disease models, with robust protocols for both in vitro and in vivo studies. This article decodes applied workflows, troubleshooting, and the impact of structure-activity insights to maximize rigor and reproducibility in translational research.

448 records 13/30 page Previous Next First page 上5页 1112131415 下5页 Last page